RxDoctor Payments Data

Jason Mudd, MD

Otolaryngology · Albuquerque, NMNPI 1881879005

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (60.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 25.4% of the total. Reporting peaked in 2019 at $2,815 and has fallen 50.3% since, to $1,398 in 2025. Among otolaryngology clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,069in general payments, 2019–2025

Across 98 payments — averaging $92.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Intersect ENT, Inc.$2K
  • Smith+Nephew$2K
  • Medical Device Business Services, Inc.$917
  • Medtronic$909
  • Sanofi$252
  • plus $1K from 13 others

What the payments were for

  • Travel & lodging$5,43960%
  • Food & beverage$3,59640%
  • Education$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,069 in reported general payments places this provider in the 95th percentile of 39 otolaryngology providers in New Mexico.

See all otolaryngology providers in New Mexico

Medicare billing

Part B allowed, 2024
$173,921
Medicare patients
429
Services billed
1,922

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab18$105,432
Ipratropium Bromide81$1,806
Fluticasone Propionate50$707
Omeprazole51$658
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort13$605
Famotidine34$386
Azelastine Hcl22$331
Diazepam30$302
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$261
Triamcinolone Acetonide12$185
Cephalexin20$165
Montelukast Sodium11$165
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$152
Levothyroxine Sodium17$140
Ciprofloxacin Hcl17$130

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →